+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
From
From
From
From
From
Venous Thromboembolism (VTE): Epidemiology Forecast to 2034 - Product Thumbnail Image

Venous Thromboembolism (VTE): Epidemiology Forecast to 2034

  • Report
  • March 2026
  • 58 Pages
  • Global
From
Hemophilia A (Factor VIII Deficiency) - Global Clinical Trials Review, 2026 - Product Thumbnail Image

Hemophilia A (Factor VIII Deficiency) - Global Clinical Trials Review, 2026

  • Clinical Trials
  • March 2026
  • 501 Pages
  • Global
From
Eosinophilic Esophagitis - Global Clinical Trials Review, 2026 - Product Thumbnail Image

Eosinophilic Esophagitis - Global Clinical Trials Review, 2026

  • Clinical Trials
  • March 2026
  • 145 Pages
  • Global
From
From
From
From
Hyperthyroidism - Global Clinical Trials Review, 2026 - Product Thumbnail Image

Hyperthyroidism - Global Clinical Trials Review, 2026

  • Clinical Trials
  • February 2026
  • 127 Pages
  • Global
From
Hyperlipidemia - Global Clinical Trials Review, 2026 - Product Thumbnail Image

Hyperlipidemia - Global Clinical Trials Review, 2026

  • Clinical Trials
  • February 2026
  • 1320 Pages
  • Global
From
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more